Skip to content

Predictive value of plasma microRNA-140-3p for restenosis in patients with lower extremity arterial occlusive disease undergoing interventional procedures

Predictive value of plasma microRNA-140-3p for restenosis in patients with lower extremity arterial occlusive disease undergoing interventional procedures

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-16009809
Enrollment
Unknown
Registered
2016-11-10
Start date
1990-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lower extremity arterial occlusive disease

Interventions

Gold Standard:
Index test:

Sponsors

Yantai Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients were received interventional treatment for LEAOD at Yantai Hospital of Traditional Chinese Medicine were recruited in our study.

Exclusion criteria

Exclusion criteria: 1. patients without taking anti-platelet aggregation drugs after undergoing stent implantation or having renal inadequacy; 2. patients who had restenosis in two or more locations and in grafting vessels after revascularization which was given 1 month after the diagnosis of restenosis; 3. patients with a severe dysfunction in left ventricular whose ejection fraction is less than 40%; 4. patients with dysfunction in liver, kidney, lung, brain and other important organs; 5. patients with connective tissue disease, autoimmune diseases or malignancies; 6. patients with a history of acute myocardial infarction.

Design outcomes

Primary

MeasureTime frame
plasma microRNA-140-3p;

Countries

China

Contacts

Public ContactZhonghua Jiang

Yantai Hospital of Traditional Chinese Medicine

zhonghuajzhh@163.com+86 15575070919

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026